Literature DB >> 1478682

Intravenous injection of interferon-gamma inhibits the proliferation of Listeria monocytogenes in the liver but not in the spleen and peritoneal cavity.

J A Langermans1, M E van der Hulst, P H Nibbering, P H van der Meide, R van Furth.   

Abstract

In the present study the effects of intravenous administration of recombinant interferon-gamma (IFN-gamma) on both the proliferation of Listeria monocytogenes in the liver and spleen of mice and the listericidal activity of their peritoneal macrophages were investigated. A single intravenous injection of 1 x 10(6) U or three injections of 2 x 10(5) U recombinant IFN-gamma (rIFN-gamma) induced optimal activation of resident and exudate peritoneal macrophages, as judged by their ability to inhibit the intracellular proliferation of Toxoplasma gondii and their enhanced release of H2O2 and NO2-. The rate of intracellular killing of L. monocytogenes by the rIFN-gamma-activated resident and exudate macrophages was not higher than that by resident macrophages. Addition of 10 ng lipopolysaccharides (LPS) to the rIFN-gamma also did not enhance the bactericidal activity of the activated peritoneal macrophages. The decrease in the number of L. monocytogenes in the peritoneal cavity of mice that had received an i.p. injection of 1 x 10(4) U rIFN-gamma was similar to that in control mice. Intravenous administration of 1 x 10(5) rIFN-gamma activated cells in the liver, as indicated by the increased expression of Ia antigen, and reduced the rate of proliferation of L. monocytogenes in the liver relative to that in control mice when 0.1 LD50 or 1 LD50 L. monocytogenes were injected. However, when 10 LD50 L. monocytogenes were administered there was no effect on their proliferation. The number of L. monocytogenes found initially in the spleen of rIFN-gamma-treated mice was 20-30% of that in the spleen of control mice, but the rate of proliferation of L. monocytogenes was not reduced. These divergent results for the proliferation of L. monocytogenes in the liver, spleen and peritoneal cavity indicate that cells other than macrophages and/or as yet unknown local factors play an important role in the listericidal activity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1478682      PMCID: PMC1421708     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  29 in total

1.  Killing of Listeria monocytogenes by inflammatory neutrophils and mononuclear phagocytes from immune and nonimmune mice.

Authors:  C J Czuprynski; P M Henson; P A Campbell
Journal:  J Leukoc Biol       Date:  1984-02       Impact factor: 4.962

2.  Protection of mice against the intracellular bacterium Listeria monocytogenes by recombinant immune interferon.

Authors:  A F Kiderlen; S H Kaufmann; M L Lohmann-Matthes
Journal:  Eur J Immunol       Date:  1984-10       Impact factor: 5.532

3.  Divergent changes in antimicrobial activity after immunologic activation of mouse peritoneal macrophages.

Authors:  J T van Dissel; J J Stikkelbroeck; M T van den Barselaar; W Sluiter; P C Leijh; R van Furth
Journal:  J Immunol       Date:  1987-09-01       Impact factor: 5.422

4.  Inability of recombinant interferon-gamma to activate the antibacterial activity of mouse peritoneal macrophages against Listeria monocytogenes and Salmonella typhimurium.

Authors:  J T van Dissel; J J Stikkelbroeck; B C Michel; M T van den Barselaar; P C Leijh; R van Furth
Journal:  J Immunol       Date:  1987-09-01       Impact factor: 5.422

5.  Macrophage activation to kill Leishmania major: activation of macrophages for intracellular destruction of amastigotes can be induced by both recombinant interferon-gamma and non-interferon lymphokines.

Authors:  C A Nacy; A H Fortier; M S Meltzer; N A Buchmeier; R D Schreiber
Journal:  J Immunol       Date:  1985-11       Impact factor: 5.422

6.  Mouse macrophages stimulated by recombinant gamma interferon to kill tumor cells are not bactericidal for the facultative intracellular bacterium Listeria monocytogenes.

Authors:  P A Campbell; B P Canono; J L Cook
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

Review 7.  Interferon-gamma, the activated macrophage, and host defense against microbial challenge.

Authors:  H W Murray
Journal:  Ann Intern Med       Date:  1988-04       Impact factor: 25.391

8.  Interferon-gamma: the major mediator of resistance against Toxoplasma gondii.

Authors:  Y Suzuki; M A Orellana; R D Schreiber; J S Remington
Journal:  Science       Date:  1988-04-22       Impact factor: 47.728

9.  The origin and kinetics of mononuclear phagocytes.

Authors:  R van Furth; Z A Cohn
Journal:  J Exp Med       Date:  1968-09-01       Impact factor: 14.307

10.  Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.

Authors:  C F Nathan; H W Murray; M E Wiebe; B Y Rubin
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

View more
  7 in total

1.  A defective Th1 response of the spleen in the initial phase may explain why splenectomy helps prevent a Listeria infection.

Authors:  N Kuranaga; M Kinoshita; T Kawabata; N Shinomiya; S Seki
Journal:  Clin Exp Immunol       Date:  2005-04       Impact factor: 4.330

2.  Assessment of the correlation between nitrite concentration and listericidal activity in cultures of resident and elicited murine macrophages.

Authors:  J N Higginbotham; S B Pruett
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

3.  Treatment with anti-interleukin-10 monoclonal antibody enhances early resistance to but impairs complete clearance of Listeria monocytogenes infection in mice.

Authors:  R D Wagner; N M Maroushek; J F Brown; C J Czuprynski
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

4.  Effect of IFN-gamma and endogenous TNF on the histopathological changes in the liver of Listeria monocytogenes-infected mice.

Authors:  J A Langermans; D M Mayanski; P H Nibbering; M E van der Hulst; J S van de Gevel; R van Furth
Journal:  Immunology       Date:  1994-02       Impact factor: 7.397

5.  Tumour necrosis factor, but not interferon-gamma, is essential for acquired resistance to Listeria monocytogenes during a secondary infection in mice.

Authors:  J N Samsom; J A Langermans; H F Savelkoul; R van Furth
Journal:  Immunology       Date:  1995-10       Impact factor: 7.397

Review 6.  A Comparison of Oral and Intravenous Mouse Models of Listeriosis.

Authors:  Michelle G Pitts; Sarah E F D'Orazio
Journal:  Pathogens       Date:  2018-01-20

7.  IL-15Rα-Independent IL-15 Signaling in Non-NK Cell-Derived IFNγ Driven Control of Listeria monocytogenes.

Authors:  Madhuparna Nandi; Mitterrand Muamba Moyo; Sakina Orkhis; Jeanne Masunga Faida Mobulakani; Marc-André Limoges; Fjolla Rexhepi; Marian Mayhue; Anny Armas Cayarga; Gisela Cofino Marrero; Subburaj Ilangumaran; Alfredo Menendez; Sheela Ramanathan
Journal:  Front Immunol       Date:  2021-12-10       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.